TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk☆
- 31 March 2003
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 88 (3), 326-332
- https://doi.org/10.1016/s0090-8258(02)00074-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Cervical cancer in older women: A molecular analysis of human papillomavirus types, HLA types, and p53 mutationsAmerican Journal of Obstetrics and Gynecology, 1998
- Polymorphisms of the TAP2 gene may influence antibody response to live measles vaccine virusVaccine, 1997
- HLA control in the progression of human papillomavirus infectionsSeminars in Cancer Biology, 1996
- A comprehensive approach for typing the alleles of the HLA‐B locus by automated sequencingTissue Antigens, 1995
- The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancerNature Medicine, 1995
- Variability of Human Papillomavirus DNA Testing in a Longitudinal Cohort of Young WomenObstetrics & Gynecology, 1993
- Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancerHuman Immunology, 1993
- HLA class I expression and HPV‐16 sequences in premalignant and malignant lesions of the cervixTissue Antigens, 1993
- Applied Logistic RegressionTechnometrics, 1992
- HLA antigens and cervical carcinomaNature, 1992